Norcantharidin induces HT-29 colon cancer cell apoptosis through the αvβ6-extracellular signal-related kinase signaling pathway

Cancer Science

Volumn 100, Issue 12, 2009, Pages 2302-2308

  Peng, Cheng ^a   Liu, Xiangqun ^b   Liu, Enyu ^a   Xu, Kesen ^a   Niu, Weibo ^a   Chen, Rong ^c   Wang, Jiayong ^a   Zhang, Zhaoyang ^a   Lin, Pengfei ^a   Wang, Jian ^a   Agrez, Michael ^d   Niu, Jun ^a  

^a Department of General Surgery ^*  (China)

^b SHANDONG UNIVERSITY   (China)

^c SHANDONG UNIVERSITY   (China)

^d UNIVERSITY OF NEWCASTLE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ALPHAVBETA6 INTEGRIN; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; GELATINASE B; MITOGEN ACTIVATED PROTEIN KINASE; NORCANTHARIDIN;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CELL SECRETION; CELL STRAIN HT29; COLON CANCER; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ANTIGENS, NEOPLASM; APOPTOSIS; BICYCLO COMPOUNDS, HETEROCYCLIC; COLONIC NEOPLASMS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HT29 CELLS; HUMANS; INTEGRINS; SIGNAL TRANSDUCTION;

EID: 70649101084     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2009.01320.x     Document Type: Article

References (36)

1. Zhang L, Sun X, Zhang ZR. An investigation on liver: targeting microemulsions of norcantharidin. Drug Deliv 2005, 12:289-295.
2. Fan YZ, Fu JY, Zhao ZM, Chen CQ. Influence of norcantharidin on proliferation, proliferation-related gene proteins proliferating cell nuclear antigen and Ki-67 of human gallbladder carcinoma GBC-SD cells. Hepatobiliary Pancreat Dis Int 2004, 3:603-607.
3. An WW, Wang MW, Tashiro S, Onodera S, Ikejima T. Mitogen-activated protein kinase-dependent apoptosis in norcan-tharidin-treated A375-S2 cells is proceeded by the activation of protein kinase C. Chin Med J 2005, 118:198-203.
4. Niu J, Gu X, Turton J, Meldrum C, Howard EW, Agrez M. Integrin-mediated signalling of gelatinase B secretion in colon cancer cells. Biochem Biophys Res Commun 1998, 249:287-291.
5. Agrez M, Gu XH, Turton J. The alpha v beta 6 integrin induces gelatinase B secretion in colon cancer cells. Int J Cancer 1999, 81:90-97.
6. Niu J, Gu X, Ahmed N. The alphaVbeta6 integrin regulates its own expression with cell crowding: implications for tumour progression. Int J Cancer 2001, 92:40-48.
7. Yang GY, Xu KS, Pan ZQ. Integrin alpha v beta 6 mediates the potential for colon cancer cells to colonize in and metastasize to the liver. Cancer Sci 2008, 99:879-887.
8. Zhao-Yang Z, Ke-Sen X, Qing-Si H. Signaling and regulatory mechanisms of integrin alphavbeta6 on the apoptosis of colon cancer cells. Cancer Lett 2008, 266:209-215.
9. Ahmed N, Niu J, Dorahy DJ. Direct integrin αvβ6-ERK binding: implications for tumor growth. Oncogene 2002, 21:1370-1380.
10. Niu J, Dorahy DJ, Gu X. Integrin expression in colon cancer cells is regulated by the cytoplasmic domain of the beta6 integrin subunit. Int J Cancer 2002, 99:529-537.
11. Gu X, Niu J, Dorahy DJ, Scott R, Agrez MV. Integrin alpha (v) beta6-associated ERK2 mediates MMP-9 secretion in colon cancer cells. Br J Cancer 2002, 87:348-351.
12. Wang J, Zhang Z, Xu K. Suppression of integrin alphaupsilonbeta6 by RNA interference in colon cancer cells inhibits extracellular matrix degradation through the MAPK pathway. Int J Cancer 2008, 123:1311-7.
13. de Gramont A, Figer A, Seymour M. Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol 2000, 18:2938-2947.
14. Rayter Z, Leicester RJ, Mansi JL. Adjuvant chemotherapy for colorectal cancer. Ann R Coll Surg Engl 1995, 77:81-84.
15. Jemal A, Murray T, Ward E. Cancer statistics, 2005. CA Cancer J Clin 2005, 55:10-30.
16. Wang GS. Medical uses of mylabris in ancient China and recent studies. J Ethnopharmacol 1989, 26:147-162.
17. Fang Y, Tian SL, Li KO, Zhao SW, Wang ZY. Studies on antitumor agents II: synthesis and anticancer activity of dehydrogenated carbon cyclic analogs of norcantharidin. Acta Pharmacol Sin 1993, 28:931-935.
18. Meredith JE, Schwartz M. Integrins, adhesion and apoptosis. Trends Cell Biol 1997, 7:146-150.
19. Breuss JM, Gillett N, Lu L, Sheppard D, Pytela R. Restricted distribution of integrin beta 6 mRNA in primate epithelial tissue. J Histochem Cytochem 1993, 41:1521-1527.
20. Breuss JM, Gallo J, DeLisser HM. Expression of the beta 6 integrin subunit in development, neoplasia and tissue repair suggests a role in epithelial remodeling. J Cell Sci 1995, 108:2241-2251.
21. Bates RC, Bellovin DI, Brown C. Transcriptional activation of integrin beta6 during the epithelial-mesenchymal transition defines a novel prognostic indicator of aggressive colon carcinoma. J Clin Invest 2005, 115:339-347.
22. Zhang ZY, Xu KS, Wang JS. Integrin alphanvbeta6 acts as a prognostic indicator in gastric carcinoma. Clin Ongol 2008, 20:61-66.
23. Dong C, Davis RJ, Flavell RA. Map kinases in the immune response. Annu Rev Immunol 2002, 20:55-72.
24. Troppmair J, Bruder JT, Munoz H. Mitogen-activated protein kinase extracellular signal-regulated protein kinase activation by oncogenes, serum, and 12-O-tetradecanoylphorbol-13-acetate requires Raf and is necessary for transformation. J Biol Chem 1994, 269:7030-7035.
25. Hoshino R, Chatani Y, Yamori T. Constitutive activation of the 41-/43-kDa mitogen-activated protein kinase signaling pathway in human tumors. Oncogene 1999, 18:813-822.
26. Kohno M, Pouyssegur J. Targeting the ERK signaling pathway in cancer therapy. Ann Med 2006, 38:200-211.
27. Peng F, Wei YQ, Tian L. Induction of apoptosis by norcantharidin in human colorectal carcinoma cell lines: involvement of the CD95 receptor/ligand. J Cancer Res Clin Oncol 2002, 128:223-230.
28. YZ Fan, JY FU, ZM Zhao. Effect of norcantharidin on proliferation and invasion of human gallbladder carcinoma GBC-SD cells. World J Gastroenterol 2005, 11:2431-2437.
29. Chen YN, Cheng CC, Chen JC, Tsauer W, Hsu SL. Norcantharidin-induced apoptosis is via the extracellular signal-regulated kinase and c-Jun-NH2-terminal kinase signaling pathways in human hepatoma HepG2 cells. Br J Pharmacol 2003, 140:461-470.
30. Hart ME, Chamberlin AR, Walkom C, Sakoff JA, McCluskey A. Modified norcantharidins; synthesis, protein phosphatases 1 and 2A inhibition, and anticancer activity. Bioorg Med Chem Lett 2004, 14:1969-1973.
31. Haga A, Nagai H, Deyashiki Y. Autotaxin promotes the expression of matrix metalloproteinase-3 via activation of the MAPK cascade in human fibrosarcoma HT-1080 cells. Cancer Invest 2009, 27:384-90.
32. Nah SS, Choi IY, Yoo B, Kim YG, Moon HB, Lee CK. Advanced glycation end products increases matrix metalloproteinase-1,-3, and -13, and TNF-a in human osteoarthritic chondrocytes. FEBS Lett 2007, 581:1928-32.
33. Kok SH, Cheng SJ, Hong CY. Norcantharidin-induced apoptosis in oral cancer cells is associated with an increase of proapoptotic to antiapoptotic protein ratio. Cancer Lett 2005, 217:43-52.
34. An WW, Wang MW, Tashiro S, Onodera S, Ikejima T. Norcantharidin induces human melanoma A375-S2 cell apoptosis through mitochondrial and caspase pathways. J Korean Med Sci 2004, 19:560-566.
35. An WW, Gong XF, Wang MW, Tashiro S, Onodera S, Ikejima T. Norcantharidin induces apoptosis in HeLa cells through caspase, MAPK, and mitochondrial pathways. Acta Pharmacol Sin 2004, 25:1502-1508.
36. Chen YJ, Kuo CD, Tsai YM, Yu CC, Wang GS, Liao HF. Norcantharidin induces anoikis through Jun-N-terminal kinase activation in CT26 colorectal cancer cells. Anticancer Drugs 2008, 19:55-64.